Atan Gross

Active 1997–2025

32
Papers
19,141
Citations
29
h-index
31
i10-index

Citations

Citations per year for Atan Gross1991: 2 citations1997: 1 citations1998: 38 citations1999: 135 citations2000: 352 citations2001: 376 citations2002: 409 citations2003: 395 citations2004: 271 citations2005: 196 citations2006: 197 citations2007: 165 citations2008: 148 citations2009: 116 citations2010: 141 citations2011: 107 citations2012: 96 citations2013: 99 citations2014: 71 citations2015: 80 citations2016: 73 citations2017: 93 citations2018: 130 citations2019: 496 citations2020: 692 citations2021: 738 citations2022: 648 citations2023: 549 citations2024: 786 citations2025: 407 citations2026: 10 citations1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,477 citing papers, 25.4% of this breakdownChina: 1,969 citing papers, 20.2% of this breakdownGermany: 494 citing papers, 5.1% of this breakdownUnited Kingdom: 385 citing papers, 3.9% of this breakdownFrance: 372 citing papers, 3.8% of this breakdownItaly: 333 citing papers, 3.4% of this breakdownCanada: 310 citing papers, 3.2% of this breakdownJapan: 274 citing papers, 2.8% of this breakdownAustralia: 272 citing papers, 2.8% of this breakdownSpain: 201 citing papers, 2% of this breakdownSouth Korea: 184 citing papers, 1.9% of this breakdownIndia: 182 citing papers, 1.9% of this breakdown
0%25.4%Other 23.6%

Fields

  • Biochemistry, Genetics and Molecular Biology52.2%
  • Medicine33.7%
  • Immunology and Microbiology5.8%
  • Neuroscience2.2%
  • Agricultural and Biological Sciences1.4%
  • Engineering1%
  • Other3.7%

Topics

  • Cell death mechanisms and regulation10.5%
  • Mitochondrial Function and Pathology4.5%
  • Autophagy in Disease and Therapy4.3%
  • Ferroptosis and cancer prognosis3.9%
  • Inflammasome and immune disorders3.1%
  • RNA Interference and Gene Delivery2%
  • Other71.7%

Coauthors

All papers

Open in search
  1. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gerald M. Cohen, Marcus Conrad, Juan R. Cubillos‐Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Ted M. Dawson, Valina L. Dawson, Vincenzo De Laurenzi, Ruggero De Maria, Klaus‐Michael Debatin, Ralph J. DeBerardinis, Mohanish Deshmukh, Nicola Di Daniele, Francesco Di Virgilio, Vishva M. Dixit, Scott J. Dixon, Colin S. Duckett, Brian David Dynlacht, Wafik S. El‐Deiry, John W. Elrod, Gian María Fimia, Simone Fulda, Ana J. García‐Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Pierre Golstein, Eyal Gottlieb, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Atan Gross, György Hajnóczky, J. Marie Hardwick, Isaac S. Harris, Michael O. Hengartner, Claudio Hetz, Hidenori Ichijo, Marja Jäättelä, Bertrand Joseph, Philipp J. Jost, Philippe Juin, William J. Kaiser, Michael Karin, Thomas Kaufmann, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Richard A. Knight, Sharad Kumar, Sam W. Lee, John J. Lemasters, Beth Levine, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos López-Otı́n, Scott W. Lowe, Tom Luedde, Enrico Lugli, Marion MacFarlane, Frank Madeo, Michal Malewicz, Walter Malorni, Gwenola Manic and 69 more - Cell Death and Differentiation 2018 cited by 6,498

  2. BCL-2 family members and the mitochondria in apoptosis

    Authors: , , - Genes & Development 1999 cited by 3,647

  3. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c

    Authors: , , , , , , , - Genes & Development 2000 cited by 1,255

  4. An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate

    Authors: , , , , , , , , , - Nature Communications 2015 cited by 247

  5. MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria

    Authors: , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2010 cited by 221

  6. Non-apoptotic functions of BCL-2 family proteins

    Authors: , - Cell Death and Differentiation 2017 cited by 198

  7. MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 94

  8. Mitochondrial plasticity in cell fate regulation

    Authors: , - Journal of Biological Chemistry 2019 cited by 139

  9. A ROS rheostat for cell fate regulation

    Authors: , - Trends in Cell Biology 2012 cited by 185

  10. MTCH2 cooperates with MFN2 and lysophosphatidic acid synthesis to sustain mitochondrial fusion

    Authors: , , , , , - EMBO Reports 2023 cited by 22

  11. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death

    Authors: , , , , , , , , - Journal of Biological Chemistry 1999 cited by 1,062

  12. BCL2 family in DNA damage and cell cycle control

    Authors: , , - Cell Death and Differentiation 2006 cited by 486

  13. tBid Undergoes Multiple Conformational Changes at the Membrane Required for Bax Activation

    Authors: , , , , , , , , - Journal of Biological Chemistry 2013 cited by 100

  14. Mitochondrial carrier homolog 2 is necessary for AML survival

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 34

  15. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis

    Authors: , , , - The EMBO Journal 1998 cited by 1,093

  16. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

    Authors: , , , , , , , - Nature 1999 cited by 998

  17. BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation

    Authors: , , , , , , , - Cell Death and Differentiation 2011 cited by 131

  18. MTCH2 controls energy demand and expenditure to fuel anabolism during adipogenesis

    Authors: , , , , , , , , , , , , , , , , - The EMBO Journal 2025 cited by 19

  19. The ATM–BID pathway regulates quiescence and survival of haematopoietic stem cells

    Authors: , , , , , , , , - Nature Cell Biology 2012 cited by 146

  20. The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel D. De Carvalho, Mark D. Minden, Gary D. Bader, Ken D. Stark, Paul J. LeBlanc, Aaron D. Schimmer - Cell stem cell 2019 cited by 59

  21. Proapoptotic BID Is an ATM Effector in the DNA-Damage Response

    Authors: , , , , , , , , , - Cell 2005 cited by 220

  22. A Role for Proapoptotic BID in the DNA-Damage Response

    Authors: , , , , , - Cell 2005 cited by 239

  23. Mutagenesis of the BH3 Domain of BAX Identifies Residues Critical for Dimerization and Killing

    Authors: , , , - Molecular and Cellular Biology 1998 cited by 210

  24. BCL-2 family proteins as regulators of mitochondria metabolism

    Authors: - Biochimica et Biophysica Acta (BBA) - Bioenergetics 2016 cited by 129